Trial · NCT03729362
Results by group110
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 110
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline to Week 52 in 6 Minute Walk Distance (6MWD) | Cipaglucosidase Alfa/Miglustat | 21.31 | Standard Error 11.56 | meter | |
| Change From Baseline to Week 52 in 6 Minute Walk Distance (6MWD) | Alglucosidase Alfa/Placebo | 7.10 | Standard Error 7.043 | meter | |
| Change From Baseline to Week 52 in Sitting Forced Vital Capacity (FVC; % Predicted) | Cipaglucosidase Alfa/Miglustat | -1.04 | Standard Error 0.624 | percentage of predicted FVC | |
| Change From Baseline to Week 52 in Sitting Forced Vital Capacity (FVC; % Predicted) | Alglucosidase Alfa/Placebo | -3.70 | Standard Error 0.953 | percentage of predicted FVC | |
| Change From Baseline to Week 52 in the Manual Muscle Test (MMT) Score for the Lower Extremities | Cipaglucosidase Alfa/Miglustat | 1.64 | Standard Error 0.388 | score on a scale | |
| Change From Baseline to Week 52 in the Manual Muscle Test (MMT) Score for the Lower Extremities | Alglucosidase Alfa/Placebo | 0.68 | Standard Error 0.603 | score on a scale | |
| Change From Baseline to Week 26 in 6MWD | Cipaglucosidase Alfa/Miglustat | 16.45 | Standard Error 3.360 | meter | |
| Change From Baseline to Week 26 in 6MWD | Alglucosidase Alfa/Placebo | 8.28 | Standard Error 5.168 | meter | |
| Change From Baseline to Week 52 in the Total Score for the Patient- Reported Outcomes Measurement Information System (PROMIS®) - Physical Function | Cipaglucosidase Alfa/Miglustat | 1.98 | Standard Error 0.921 | score on a scale | |
| Change From Baseline to Week 52 in the Total Score for the Patient- Reported Outcomes Measurement Information System (PROMIS®) - Physical Function | Alglucosidase Alfa/Placebo | 0.11 | Standard Error 1.406 | score on a scale | |
| Change From Baseline to Week 52 in the Total Score for the PROMIS® - Fatigue | Cipaglucosidase Alfa/Miglustat | -1.90 | Standard Error 0.585 | score on a scale | |
| Change From Baseline to Week 52 in the Total Score for the PROMIS® - Fatigue | Alglucosidase Alfa/Placebo | -1.94 | Standard Error 0.901 | score on a scale | |
| Change From Baseline to Week 52 in the Total Score for the Gait, Stairs, Gowers' Maneuver, and Chair (GSGC) | Cipaglucosidase Alfa/Miglustat | -0.567 | Standard Error 0.280 | score on a scale | |
| Change From Baseline to Week 52 in the Total Score for the Gait, Stairs, Gowers' Maneuver, and Chair (GSGC) | Alglucosidase Alfa/Placebo | 0.847 | Standard Error 0.440 | score on a scale | |
| Change From Baseline to Week 52 in Rasch-Built Pompe-Specific Activity (R-PAct) Total Score | Cipaglucosidase Alfa/Miglustat | 0.04 | Standard Error 0.387 | score on a scale | |
| Change From Baseline to Week 52 in Rasch-Built Pompe-Specific Activity (R-PAct) Total Score | Alglucosidase Alfa/Placebo | 0.51 | Standard Error 0.567 | score on a scale | |
| Change From Baseline to Week 52 in European Quality of Life-5 Dimensions 5 Response Levels (EQ-5D-5L) Based on the EuroQol Visual Analogue Scale (EQ VAS) Quantitative Score | Cipaglucosidase Alfa/Miglustat | 0.03 | Standard Error 1.542 | score on a scale | |
| Change From Baseline to Week 52 in European Quality of Life-5 Dimensions 5 Response Levels (EQ-5D-5L) Based on the EuroQol Visual Analogue Scale (EQ VAS) Quantitative Score | Alglucosidase Alfa/Placebo | 3.61 | Standard Error 2.400 | score on a scale | |
| Change From Baseline to Week 52 in Sitting Slow Vital Capacity (SVC) % Predicted | Cipaglucosidase Alfa/Miglustat | -2.527 | Standard Error 0.977 | percentage of predicted SVC | |
| Change From Baseline to Week 52 in Sitting Slow Vital Capacity (SVC) % Predicted | Alglucosidase Alfa/Placebo | -5.368 | Standard Error 1.527 | percentage of predicted SVC |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03729362/results